SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-021877
Filing Date
2024-07-02
Accepted
2024-07-02 09:29:06
Documents
17
Period of Report
2024-06-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20240627_8k.htm   iXBRL 8-K 30308
2 EXHIBIT 10.1 ex_693312.htm EX-10.1 94743
3 EXHIBIT 99.1 ex_693313.htm EX-99.1 10451
8 ex_693313img001.jpg GRAPHIC 2717
  Complete submission text file 0001437749-24-021877.txt   295324

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dyai-20240701.xsd EX-101.SCH 3408
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20240701_def.xml EX-101.DEF 11423
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20240701_lab.xml EX-101.LAB 15309
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20240701_pre.xml EX-101.PRE 11583
20 EXTRACTED XBRL INSTANCE DOCUMENT dyai20240627_8k_htm.xml XML 2850
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

IRS No.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 241093093
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)